Key stats
About Invesco Nasdaq Biotechnology ETF
Expense ratio
0.19%
Home page
Inception date
Jun 11, 2021
IBBQ provides exposure to US biotech and pharma companies that are exclusively listed on the NASDAQ Stock Market. The index includes companies classified under the biotechnology or pharmaceuticals sub sector of the Industry Classification Benchmark. Companies from any capitalization may be included, but since weighting is based on market cap, it produces a basket that heavily favors large-caps and concentrates exposure in the top names. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. IBBQ may miss opportunities in companies traded on the NYSE, which several of the other similar funds are eligible to hold. The index is rebalanced quarterly and reconstituted annually in December.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks100.01%
Health Technology97.79%
Commercial Services1.97%
Health Services0.23%
Bonds, Cash & Other−0.01%
Miscellaneous−0.01%
Stock breakdown by region
North America99.96%
Europe0.04%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history